JAK2 and acute lymphoblastic leukemia: Similarly, the BCR-ABL1 fusion, particularly the p190 isoform in Ph-positive B-ALL, directly activates STAT5, either independently or via JAK2, driving proliferation and correlating with poor prognosis (200).